Characterization of Admission Medication Reconciliations Performed by Pharmacists in a Pediatric Institution:

Insights

Pediatric medication reconciliation (MedRec) identified risk factors for pharmacist interventions. Patients with multiple home medications, especially those in the PICU or with cardiac/endocrine issues, require prioritized MedRec to prevent adverse drug events.

Area of Science:

  • Pediatric pharmacology
  • Patient safety
  • Healthcare quality improvement

Background:

  • Children face higher risks of medication errors and adverse effects than adults.
  • Proactive identification of at-risk pediatric patients is recommended to prevent medication-related adverse events.
  • This study aimed to identify risk factors in admitted pediatric patients necessitating pharmacist intervention during medication reconciliation (MedRec).

Purpose of the Study:

  • To evaluate pediatric admissions to identify specific risk factors.
  • To determine factors that require pharmacist intervention during the MedRec process.
  • To enhance patient safety through targeted medication reconciliation.

Main Methods:

  • Prospective study of pediatric patient admissions until 500 encounters were achieved.
  • Pharmacy staff collected medication histories; pediatric pharmacists performed MedRec.
  • Primary outcome: identification of high-risk transition of care factors based on pharmacist interventions.

Main Results:

  • 331 interventions were made for 127 patients; 59.2% were moderate or significant severity.
  • Patients with ≥2 home medications were more likely to need any intervention (p < 0.0001).
  • Patients with ≥5 home medications had a higher likelihood of significant interventions.

Conclusions:

  • Identifying patients with multiple home medications enables focused intervention efforts.
  • Prioritize MedRec for PICU admissions or patients with cardiology/endocrinology diagnoses due to higher medication needs.
  • Tailor MedRec strategies to institutional resources and quality assessments for optimal pediatric patient safety.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
159
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
204
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
184
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
146
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
190
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
99